Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New inhaler tested to help COPD patients breathe easier

NCT ID NCT06035393

Summary

This study tested a new inhaled medication, HRG2005, for people with moderate to severe chronic obstructive pulmonary disease (COPD). It aimed to see if the treatment could improve lung function and reduce the frequency of serious symptom flare-ups over nearly a year. The study was stopped early and involved comparing the new inhaler against an existing standard treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Peking University Third Hospital

    Beijing, Beijing Municipality, 100191, China

Conditions

Explore the condition pages connected to this study.